Arix Bioscience financials at a glance
| Year | Year | 2017 | 2018 | 2019 | 2020 | 2016 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
£7.40M | £52.50M | £-58.14M | £135.77M | £1.49M | £-53.58M | £-30.66M | £0.00M | £0.00M |
| GM % | Gross Margin % |
|
100.00% | 100.00% | 0.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
-97.87% | 71.37% | 0.00% | 94.26% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
£-0.11 | £0.30 | £-0.53 | £0.89 | £188.16 | £0.00 | |||
| Div. | Dividends |
|
£0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0.00% | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
86.2m | 124.87m | 125.6m | 130.53m | 0m | 124.1m | 124.1m | 0m | 0m |
| OCF | Operating Cash Flow |
|
£-8.78M | £-11.06M | £-8.47M | £-6.73M | £-5.59M | £-7.14M | £-4.64M | £0.00M | £0.00M |
| FCF | Free Cash Flow |
|
£-8.79M | £0.00M | £-8.48M | £-6.74M | £-6.26M | £-7.24M | £-4.65M | £0.00M | £0.00M |
| FCFS | Free Cash Flow Per Share |
|
£-0.11 | £-0.09 | £-0.07 | £-0.05 | £0.00 | £-0.06 | £-0.04 | £0.00 | £0.00 |